1020066-74-3Relevant articles and documents
Pharmacological exploitation of the peroxisome proliferator-activated receptor γ agonist ciglitazone to develop a novel class of androgen receptor-ablative agents
Yang, Jian,Wei, Shuo,Wang, Da-Sheng,Wang, Yu-Chieh,Kulp, Samuel K.,Chen, Ching-Shih
, p. 2100 - 2107 (2008)
On the basis of our finding that the peroxisome proliferator-activated receptor γ (PPARγ) agonist ciglitazone at high doses was able to mediate PPARγ-independent transcriptional repression of androgen receptor (AR) in a tumor cell-specific manner, we used